<DOC>
<DOCNO>EP-0655242</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Use of coumarin derivatives in the treatment of NO induced disorders.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31366	A61K3137	A61K31445	A61K31445	A61K31495	A61K31495	A61K31535	A61K31535	A61K3154	A61K3154	C07D31100	C07D31108	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	C07D311	C07D311	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention therefore relates to the use of coumarins of the general formula I 
<
IMAGE
>
  wherein R
<
1
>
 and R
<
6
>
 are defined as indicated in the claims, for the control and prevention of diseases which result due to an increased NO level.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
CASSELLA FARBWERKE MAINKUR AG
</APPLICANT-NAME>
<APPLICANT-NAME>
CASSELLA AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
KLEMM PETER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
OSTROWSKI JOERG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHOENAFINGER KARL DR
</INVENTOR-NAME>
<INVENTOR-NAME>
KLEMM, PETER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
OSTROWSKI, JOERG, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHOENAFINGER, KARL, DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
